Key facts
- CareGlance’s last known valuation is $4.6M (Jul 2023).
- It has raised $6.0M; the latest was Later Stage VC ($4.1M) in Dec 2025.
- Notable investors include CDP Venture Capital (Rome), LIFTT, EUREKA! Venture SGR, Polihub.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for CareGlance
- ·The full record, as it builds
Funding rounds
No funding rounds for CareGlance are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CareGlance
Developer of an optical coherence tomography system designed to make a portable laser imaging system. The company's system offers portable, real-time optical coherence tomography (OCT) imaging systems with high coherence and resolution, as well as an OCT micro module with monolithic and hybrid integrations, enabling healthcare and industrial markets to achieve precise and efficient imaging for non-invasive three-dimensional imaging of tissues, materials, and surfaces.
- Sector
- Healthcare
- HQ
- Milan, Italy
- Founded
- 2019
- Employees
- 10
- Website
- careglance-srl.it/
- Ownership
- Privately Held (backing)
CareGlance doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CareGlance shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CareGlance in its N-PORT filings yet. We sweep new filings monthly.